Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of EBI-005 in Dry Eye Disease
NCT02405039Phase 3Unknown
- Sponsor
- Sesen Bio
- Start
- Apr 2015
- Primary completion
- Jun 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of isunakinra in dry eye disease (DED), sponsored by Sesen Bio. Status: unknown.
02
Drugs
isunakinra
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02405039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405039.